Survey of disease burden and clinical practices for patients with tinnitus

Quantitative survey of disease burden and clinical practices for patients with tinnitus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030240566

Enrollment

1000

Registered

2024-12-18

Start date

2024-12-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients aged 18 years or older at the time of obtaining consent 2)Patients who fully understood the consent document and gave their own voluntary consent to participate in this study

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Survey on respondents' background, disease burden, and medical treatment status - Background: gender, age group, severity of tinnitus (using the Tinnitus Handicap Inventory: THI), and status of medical institution, etc. - Disease burden, and medical treatment status: Work Productivity and Activity Impairment -General Health (WPAI-GH) Departments visited for tinnitus treatment and the number of medical institutions consulted Current of tinnitus explanation in medical institutions	—

Measure

Time frame

Survey on respondents' background, disease burden, and medical treatment status - Background: gender, age group, severity of tinnitus (using the Tinnitus Handicap Inventory: THI), and status of medical institution, etc. - Disease burden, and medical treatment status: Work Productivity and Activity Impairment -General Health (WPAI-GH) Departments visited for tinnitus treatment and the number of medical institutions consulted Current of tinnitus explanation in medical institutions

—

Secondary

Measure	Time frame
Evaluate the disease burden and medical treatment status for each background.	—

Contacts

Public ContactYuichi Yageta

KYORIN Pharmaceutical Co., Ltd

yuuichi.yageta@mb.kyorin-pharm.co.jp+81-3-6374-9708

Outcome results